Related Experiment Video

Updated: Jul 3, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

[Multidrug resistance in fungi]

Izabela Lacka1, Roland Wakieć

  • 1Katedra Technologii Leków i Biochemii, Politechnika Gdańska, Gdańsk. lackaiza@wp.pl

Postepy Biochemii
|July 10, 2008
PubMed

Insights

Multidrug resistance in pathogenic fungi is a major challenge, often caused by efflux pumps. This review explores strategies to overcome fungal drug resistance using co-administered compounds.

Area of Science:

  • Medical Mycology
  • Antimicrobial Resistance
  • Pharmacology

Background:

  • Pathogenic fungi increasingly exhibit resistance to antibiotics and chemotherapeutics.
  • Multidrug resistance (MDR) is a critical concern, driven by efflux pumps like ABC and MFS transporters.
  • Overcoming fungal MDR is essential for effective clinical chemotherapy.

Purpose of the Study:

  • To review current knowledge on proteins involved in fungal multidrug resistance.
  • To explore strategies for overcoming multidrug resistance in pathogenic fungi via pharmacological intervention.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of mechanisms of multidrug resistance in fungi.
  • Examination of chemical compounds and their modes of action in restoring drug susceptibility.

Main Results:

  • Fungal multidrug resistance is primarily mediated by the overexpression of membrane efflux transporters.
  • Two main classes of transporters, ABC and MFS, are implicated in fungal MDR.
  • Co-administration of specific chemical compounds can restore susceptibility in multidrug-resistant fungal cells.

Conclusions:

  • Pharmacological intervention targeting efflux transporters is a promising strategy against fungal MDR.
  • Understanding transporter mechanisms is key to developing effective MDR reversal agents.
  • Restoring drug susceptibility in resistant fungi is crucial for advancing chemotherapy.

More Related Videos

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis09:44

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis

Published on: June 13, 2021

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy09:06

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy

Published on: March 29, 2024

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...